CYTR - CytRx Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue100200100100
Cost of Revenue----
Gross Profit100200100100
Operating Expenses
Research Development19,840.10635,930.21243,395.57436,677.706
Selling General and Administrative12,502.04215,990.78914,164.90412,845.231
Non Recurring----
Others----
Total Operating Expenses32,971.4652,457.63257,878.12749,705.864
Operating Income or Loss-32,871.46-52,257.632-57,778.127-49,605.864
Income from Continuing Operations
Total Other Income/Expenses Net-2,114.1721,487.211-808.26319,488.684
Earnings Before Interest and Taxes-32,871.46-52,257.632-57,778.127-49,605.864
Interest Expense-3,831.211-2,754.677-2,754.677-2,754.677
Income Before Tax-34,985.632-50,770.421-58,586.39-30,117.18
Income Tax Expense0.80.80.80.8
Minority Interest----
Net Income From Continuing Ops-34,986.432-50,771.221-58,587.19-30,117.98
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-34,986.432-50,771.221-58,587.19-30,117.98
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-34,986.432-50,771.221-58,587.19-30,117.98